2024
The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention
2021
Strategies to Minimize Iodinated Contrast Volume in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Interventions
Lee SR, Dardik A, Chaar CIO. Strategies to Minimize Iodinated Contrast Volume in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Interventions. Annals Of Vascular Surgery 2021, 73: 490-495. PMID: 33556507, DOI: 10.1016/j.avsg.2021.01.081.Peer-Reviewed Original ResearchConceptsPeripheral vascular interventionsChronic kidney diseaseVascular interventionsPostcontrast acute kidney injuryChronic limb threatening ischemiaSuccessful endovascular revascularizationAcute kidney injuryCKD stage 4Limb threatening ischemiaPC-AKIEndovascular revascularizationKidney injuryUse of ICMContrast volumeKidney diseaseIntravascular lesionsContrast mediumPatientsStage 4InterventionRiskRevascularizationIschemiaInjuryTherapy